The ALS Association is committing $3.5 million, including a $1 million commitment from its Greater New York chapter, while the Tow Foundation is contributing $2.5 million.
Several of the novel variants the researchers identified are more common among individuals of Japanese ancestry than of European background.
The money is being provided under three Genome Canada funding competitions in partnership with the Canadian federal government and other groups.
Two research groups have cultured and sequenced microbes in fecal samples from healthy volunteers, producing new reference genomes for hundreds of species.
With sequence data for 551 esophageal adenocarcinomas, researchers uncovered potential prognostic alterations and mutations that may sensitize tumors to treatment.
The company is developing a methylated DNA biomarker that will predict all-cause mortality risk and risk of developing certain age-related diseases.
The submission by Curetis' distribution partner Beijing Clear Biotech used data previously collected for regulatory approvals in the US and Europe.
Last week, GenomeWeb's readers were most interested in Illumina's expansion of its clinical business in international markets.
The UK informatics startup has received funding from Innovate UK to implement an informatics platform for physicians to identify patients for genomic testing.
Researchers sequenced 45 individuals from the Caucasus and steppe region between 3,500 and 6,500 years ago, teasing out distinct populations and shared relationships.
The Human Genome Reference Program aims to build a human genome reference that better accounts for genetic diversity than the existing reference.
The diversity of the organizations that have signed the letter to CMS demonstrates widespread concern over this policy.
The firm's lab subsidiary Phenogen will provide genotyping to study the impact on women's decisions to undergo prophylactic surgery.
The index, which outperformed the Dow Jones and the Nasdaq this month, gained 11 percent and rebounded from its 11 percent loss in December.
PacBio agreed to pay attorneys' fees to settle lawsuits brought against it by investors regarding Illumina's acquisition.
The latest guidelines include new language about screening individuals with BRCA mutations and the potential utility of certain biomarker tests.
Eagle said it will use the funding to further develop its software platform for analyzing genomic and microbiomic data at scale.
Two new studies found that prenatal whole-exome sequencing could uncover clinically significant variants in an additional 8 to 12 percent of fetuses with structural anomalies.
Natera plans to harness One Lambda's commercial infrastructure when it launches its cfDNA kidney transplant rejection test this year.
With metagenomics, genomics, and other analyses, researchers saw a potential antifungal compound called cyphomycin produced by Streptomyces in an ant in Brazil.
Organically, the diagnostics segment was up 14 percent. Overall, the company's revenues grew 18 percent year over year during the quarter.
The companies will join certain of their respective technologies into a single product for low-pass whole-genome sequencing and genotype imputation.
The announcement comes one day after the company said it had sold $3 million worth of preferred stock in a transaction that eliminated its debt.
Roche Diagnostics had sales of CHF 12.88 billion in 2018. For the fourth quarter, diagnostics sales totaled CHF 3.5 billion, up 10 percent year over year.
A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.
South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.
In Science this week: the synthetic genetic system hachimoji, and more.
Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.